Enhancing Care for NOWS/NAS Patients: A Comparative Analysis of Eat/Sleep/Console vs. Modified Finnegan Neonatal Abstinence Scoring System and its Impact on Hospital Length of Stay

Location

LSU Health Sciences Center - New Orleans

Event Website

https://www.medschool.lsuhsc.edu/genetics/2023_medical_student_research_poster_symposium.aspx

Presentation Date

23-10-2023 8:29 AM

Description

Neonatal Opioid Withdrawal Syndrome/Neonatal Abstinence Syndrome (NOWS/NAS), resulting from in-utero drug and substance abuse exposure, affects 7 newborns per 1000 live births in the United States. The Modified Finnegan Neonatal Abstinence Scoring System (M-FNASS) has conventionally been employed to monitor and treat NOWS/NAS patients. However, the emerging assessment method known as Eat/Sleep/Console (ESC) has shown promising results in various hospital systems. Recent studies indicate a significant reduction in hospital stays when using the ESC model compared to M-FNASS, accompanied by improvements in other clinically significant outcomes. This study aims to retrospectively gather data from hospitals in the FMOLHS system to investigate whether ESC leads to a significant reduction in hospital stays compared to M-FNASS or other comparable methods. A retrospective chart review was conducted to collect data on the length of stay (LOS) of NOWS/NAS patients within the FMOLHS hospital system from 2019 to 2022. LOS data from patients assessed using either M-FNASS or ESC were compared, and all statistical analyses were performed using SPSS (version 28). The study included LOS data from a total of 41 patients (21 ESC, 20 M-FNASS). Patients assessed using the ESC method exhibited a substantially lower average LOS of 14.14 days, in contrast to M-FNASS, which had an average LOS of 21.3 days. Further analysis revealed a statistically significant difference between ESC and M-FNASS (p

Comments

Mentors: Drs. Brian Tran, Cydney Fondel, Mikki Bouquet, and J. Hunter Collins Our Lady of the Lake Children’s Hospital, Baton Rouge, LA

This document is currently not available here.

Share

COinS
 
Oct 23rd, 8:29 AM

Enhancing Care for NOWS/NAS Patients: A Comparative Analysis of Eat/Sleep/Console vs. Modified Finnegan Neonatal Abstinence Scoring System and its Impact on Hospital Length of Stay

LSU Health Sciences Center - New Orleans

Neonatal Opioid Withdrawal Syndrome/Neonatal Abstinence Syndrome (NOWS/NAS), resulting from in-utero drug and substance abuse exposure, affects 7 newborns per 1000 live births in the United States. The Modified Finnegan Neonatal Abstinence Scoring System (M-FNASS) has conventionally been employed to monitor and treat NOWS/NAS patients. However, the emerging assessment method known as Eat/Sleep/Console (ESC) has shown promising results in various hospital systems. Recent studies indicate a significant reduction in hospital stays when using the ESC model compared to M-FNASS, accompanied by improvements in other clinically significant outcomes. This study aims to retrospectively gather data from hospitals in the FMOLHS system to investigate whether ESC leads to a significant reduction in hospital stays compared to M-FNASS or other comparable methods. A retrospective chart review was conducted to collect data on the length of stay (LOS) of NOWS/NAS patients within the FMOLHS hospital system from 2019 to 2022. LOS data from patients assessed using either M-FNASS or ESC were compared, and all statistical analyses were performed using SPSS (version 28). The study included LOS data from a total of 41 patients (21 ESC, 20 M-FNASS). Patients assessed using the ESC method exhibited a substantially lower average LOS of 14.14 days, in contrast to M-FNASS, which had an average LOS of 21.3 days. Further analysis revealed a statistically significant difference between ESC and M-FNASS (p

https://digitalscholar.lsuhsc.edu/sommrd/2023MSRD/Posters/44